Senior insider sale
Executive Chair at LYRA THERAPEUTICS, INC. — senior position signals high conviction
$14.9K
145.37K shares
What this filing means
WAKSAL HARLAN plans to sell 145.37K shares of LYRA THERAPEUTICS, INC. valued at approximately $14.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/25/2025ACC: 0001959173-25-002702
DirectorOfficer· Executive Chair
Since Feb 2022
145.37K
Shares to sell
$14.9K
Approx. market value
145.37K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
1/31/2025
145.37KTotal acquired145.37K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2025 | Restricted Stock Vesting Compensation | 145.37K | — |
| Total | 145.37K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
145.37K
Market value
$14.9K
4/25/2025
Total
Units
145.37K
Value
$14.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/25/2025 | 145.37K | $14.9K | NASDAQ | Planned |
| Total | 145.37K | $14.9K | ||